The future of AI in healthcare innovation took center stage during a dynamic panel titled “From Concept to Clinic: Accelerating Medical Device Innovation with AI”, held as part of the Design of Medical Devices Conference, hosted by the University of Minnesota’s Institute for Engineering in Medicine.
IIB Director Patricia Khashayar along with Kevin W. Sexton (Vice Chair of Innovation for the Section of Surgical Sciences, Vanderbilt University Medical Center), Nathan Downing (Managing FDA Attorney, Gardner Law, PLLC), attended the panel moderated by Christopher Tignanelli (Co-Director, Clinical Quality, Outcomes, Discovery and Evaluation (CQODE), Scientific Co-Director, Program for Clinical, Center for Learning Health System Sciences, Associate Dean for Data Science, University of Minnesota)
The panel explored the transformative role of artificial intelligence in medical device development. Topics ranged from leveraging real-world evidence to validate AI performance, to tackling the complex regulatory pathways surrounding these technologies, and navigating the challenges of system-wide adoption in clinical environments.
The conversation emphasized the importance of cross-disciplinary collaboration to responsibly scale AI-powered innovations from early concept to clinical impact. As the medical device field rapidly evolves, the insights shared during this panel offer a compelling vision for the next era of healthcare innovation.
